Matthias Hermann Selected Research

Aspirin (Acetylsalicylic Acid)

1/2003

Selective COX-2 inhibition improves endothelial function in coronary artery disease.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthias Hermann Research Topics

Disease

8	Hypertension (High Blood Pressure) 01/2023 - 11/2003
8	Cardiovascular Diseases (Cardiovascular Disease) 01/2019 - 01/2003
7	Inflammation (Inflammations) 10/2020 - 02/2005
5	Atherosclerosis 02/2009 - 04/2005
4	Myocardial Infarction 12/2020 - 01/2007
3	Thrombosis (Thrombus) 01/2023 - 04/2005
3	Vascular Diseases (Vascular Disease) 04/2012 - 04/2008
2	Pulmonary Hypertension 01/2023 - 03/2007
2	COVID-19 04/2021 - 01/2021
2	Infarction (Infarctions) 01/2019 - 01/2007
2	Coronary Artery Disease (Coronary Atherosclerosis) 11/2010 - 01/2003
2	Rheumatoid Arthritis 04/2008 - 02/2005
1	Adjustment Disorders (Adjustment Disorder) 10/2023
1	Heart Failure 08/2023
1	Renal Insufficiency (Renal Failure) 08/2023
1	Hemorrhage 02/2023
1	Lung Diseases (Lung Disease) 01/2023
1	Thrombotic Thrombocytopenic Purpura 01/2023
1	Upper Extremity Deep Vein Thrombosis 01/2023
1	Neoplasms (Cancer) 09/2022
1	Heart Diseases (Heart Disease) 01/2022
1	Cardiogenic Shock 11/2021
1	Takotsubo Cardiomyopathy 11/2021
1	Left Ventricular Dysfunction 11/2021
1	Paresis (Hemiparesis) 11/2021
1	Down Syndrome (Down's Syndrome) 04/2021
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 04/2021
1	Hemophagocytic Lymphohistiocytosis (Hemophagocytic Syndrome) 04/2021
1	Obstructive Sleep Apnea 02/2021
1	Mucocutaneous Lymph Node Syndrome (Kawasaki Disease) 10/2020
1	Infections 10/2020
1	Fever (Fevers) 10/2020
1	ST Elevation Myocardial Infarction 01/2019
1	Acute Coronary Syndrome 04/2012
1	Rheumatic Diseases (Rheumatism) 05/2011
1	Hyperlipidemias (Hyperlipidemia) 01/2009
1	Hypotension (Low Blood Pressure) 01/2009
1	Chronic Kidney Failure (Chronic Renal Failure) 03/2007
1	Fibrosis (Cirrhosis) 03/2007
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2007

Drug/Important Bio-Agent (IBA)

4	Cyclooxygenase 2 Inhibitors (COX-2 Inhibitors)IBA 04/2005 - 01/2003
3	torcetrapibIBA 07/2012 - 01/2009
3	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 05/2011 - 11/2003
3	Proteins (Proteins, Gene)FDA Link 01/2009 - 02/2005
2	Intravenous Immunoglobulins (IVIG)FDA Link 04/2021 - 10/2020
2	Endothelins (Endothelin)IBA 03/2007 - 02/2003
2	Erythropoietin FDA Link 01/2007 - 02/2003
2	Diclofenac (SR 38)FDA LinkGeneric 02/2005 - 11/2003
2	rofecoxib (Vioxx)FDA Link 02/2005 - 11/2003
2	Celecoxib (Celebrex)FDA Link 02/2005 - 11/2003
2	SaltsIBA 02/2005 - 11/2003
1	Sodium-Glucose Transporter 2 InhibitorsIBA 08/2023
1	AgarIBA 02/2023
1	von Willebrand FactorIBA 01/2023
1	caplacizumabIBA 01/2023
1	4-amino-4'-hydroxylaminodiphenylsulfone (HADS)IBA 01/2022
1	CatecholaminesIBA 11/2021
1	remdesivirIBA 04/2021
1	SteroidsIBA 04/2021
1	Etanercept (Enbrel)FDA Link 10/2020
1	Interleukin 1 Receptor Antagonist Protein (Anakinra)FDA Link 10/2020
1	Amphetamine (Amfetamine)FDA LinkGeneric 01/2020
1	HDL LipoproteinsIBA 04/2012
1	C-Reactive ProteinIBA 04/2012
1	CholesterolIBA 04/2012
1	oxidized low density lipoproteinIBA 04/2012
1	HDL CholesterolIBA 04/2012
1	Proton Pump InhibitorsIBA 05/2011
1	Acetaminophen (Paracetamol)FDA LinkGeneric 11/2010
1	LipidsIBA 02/2009
1	PotassiumIBA 01/2009
1	candesartan cilexetil (Amias)FDA Link 01/2009
1	Triglycerides (Triacylglycerol)IBA 01/2009
1	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA 01/2009
1	Endothelin-1 (Endothelin 1)IBA 01/2009
1	dalcetrapibIBA 01/2009
1	Ramipril (Altace)FDA LinkGeneric 04/2008
1	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2008
1	Peptidyl-Dipeptidase A (Angiotensin Converting Enzyme)IBA 04/2008
1	Vitamin D FDA LinkGeneric 02/2008
1	FlavonoidsIBA 11/2007
1	AntioxidantsIBA 11/2007
1	Endothelin Receptor AntagonistsIBA 03/2007
1	Eosine Yellowish-(YS) (Eosin)IBA 01/2007
1	Hematoxylin (Haematoxylon)IBA 01/2007
1	Endothelium-Dependent Relaxing Factors (Endothelium Derived Relaxing Factor)IBA 12/2006
1	Nitric Oxide Synthase (NO Synthase)IBA 12/2006
1	Nitric Oxide (Nitrogen Monoxide)FDA Link 12/2006
1	Cyclooxygenase InhibitorsIBA 01/2006

Therapy/Procedure

5	Cardiac Rehabilitation 10/2023 - 01/2018
5	Therapeutics 10/2020 - 01/2003
1	Parenteral Nutrition 01/2023
1	Catheters 01/2023
1	Central Venous Catheters 01/2023
1	Lasers (Laser) 09/2022
1	Deep Sedation 11/2021
1	Artificial Respiration (Mechanical Ventilation) 11/2021
1	Duration of Therapy 01/2021
1	Patient Readmission 01/2019
1	Ligation 01/2007